Nektar Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology.

CEO

Howard W. Robin

CEOHoward W. Robin

Employees

137

Employees137

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1990

Founded1990

Employees

137

Employees137

NKTR Key Statistics

Market cap

229.52M

Market cap229.52M

Price-Earnings ratio

-0.85

Price-Earnings ratio-0.85

Dividend yield

—

Dividend yield—

Average volume

4.41M

Average volume4.41M

High today

$1.35

High today$1.35

Low today

$1.20

Low today$1.20

Open price

$1.33

Open price$1.33

Volume

4.72M

Volume4.72M

52 Week high

$1.75

52 Week high$1.75

52 Week low

$0.4126

52 Week low$0.4126

Nektar Therapeutics

Why Robinhood?

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. Show more

NKTR Key Statistics

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology.